Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT03984565
PHASE2

PAIN: A Project Assessing the Impact of a Novel Cannabinoid Product

Sponsor: Staci Gruber, Ph.D.

View on ClinicalTrials.gov

Summary

This study is a clinical trial of a high-cannabidiol (CBD) sublingual product compared to placebo for 9 weeks in patients with chronic pain conditions. The study will assess the impact of CBD on chronic pain symptoms, conventional medication use, clinical state, quality of life, cognition, and biomarkers.

Key Details

Gender

All

Age Range

21 Years - Any

Study Type

INTERVENTIONAL

Enrollment

25

Start Date

2024-06-27

Completion Date

2026-09

Last Updated

2026-03-30

Healthy Volunteers

No

Conditions

Interventions

DRUG

Cannabidiol

High-CBD, low-THC sublingual product formulated in palm oil

DRUG

Placebo

Placebo sublingual product formulated in palm oil with supplemental terpenes to match CBD product.

Locations (1)

McLean Hospital

Belmont, Massachusetts, United States